0001593968-24-000003.txt : 20240102 0001593968-24-000003.hdr.sgml : 20240102 20240102162924 ACCESSION NUMBER: 0001593968-24-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231229 FILED AS OF DATE: 20240102 DATE AS OF CHANGE: 20240102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brockstedt Dirk G. CENTRAL INDEX KEY: 0001635616 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38997 FILM NUMBER: 24502851 MAIL ADDRESS: STREET 1: C/O ADURO BIOTECH, INC. STREET 2: 740 HEINZ AVENUE CITY: BERKELEY STATE: CA ZIP: 94710 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RAPT Therapeutics, Inc. CENTRAL INDEX KEY: 0001673772 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 473313701 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 489-9000 MAIL ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FLX Bio, Inc. DATE OF NAME CHANGE: 20160504 4 1 primary_01.xml PRIMARY DOCUMENT X0508 4 2023-12-29 0001673772 RAPT Therapeutics, Inc. RAPT 0001635616 Brockstedt Dirk G. C/O RAPT THERAPEUTICS, INC., 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 false true false false Chief Scientific Officer false Common Stock 2023-12-29 4 M false 8000 6.18 A 27070 D Employee Stock Option (right to buy) 6.18 2023-12-29 4 M false 8000 0 A 2028-03-27 Common Stock 8000 7690 D Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years. /s/ Rodney Young, Attorney-in-Fact for Dirk G Brockstedt 2024-01-02